Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The addition of 62,000 square meters of new development in 2026 will more than double the total footprint of the site to 108,000 square meters.
July 7, 2025
By: Charlie Sternberg
Axplora has announced a transformative €35 million ($41.2 million) expansion at its Farmabios site in Gropello Cairoli, Italy.
This latest investment builds on the €45 million already committed over the past five years, bringing Axplora’s recent investment in Farmabios to over €80 million.
The addition of 62,000 square meters of new development in 2026 will more than double the total footprint of the site to 108,000 square meters. This will be more than ten times its original size in 1968.
“This expansion is not just a matter of scale, it’s about shaping the future of pharmaceutical manufacturing,” said Mario Di Giacomo, Managing Director of Farmabios. “We are investing with purpose: to enhance our capabilities, support our partners, and continue leading with innovation and integrity.”
This expansion follows a period of accelerated growth at Farmabios. Key initiatives include the construction of a new micronisation department, expanded warehouse capacity, and the RS40 building – a state-of-the-art unit purpose-built for the safe and efficient handling of High Potent APIs (HPAPIs).
Designed in accordance with the most stringent safety and containment standards, RS40 employs a comprehensive exposure control strategy, including a layout based on exposure zoning that ensures strict segregation of high-potency operations within dedicated suites. The facility supports an Occupational Exposure Limit (OEL) as low as 10 nanograms per cubic meter and complies fully with OEB5 containment criteria. Its design incorporates stand-alone workshops and fully isolated process rooms to mitigate cross-contamination risks, offering maximum protection for both operators and products. In addition, the micronisation rooms are equipped with isolators specifically designed for HPAPI processing, ensuring safe handling of potent compounds at every stage.
“The Farmabios site reflects Axplora’s commitment to being a proactive, science-led, and sustainable partner,” said Martin Meeson, CEO of Axplora. “Every investment we make is guided by the ambition to deliver greater value to our customers, while raising the bar in reliability, speed and efficiency.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !